- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kodiak Sciences Inc (KOD)
Assess today's live Kodiak Sciences Inc (KOD) share price, performance and insights using our live NASDAQ: KOD stock exchange data.
Analyse the historical data and Kodiak Sciences Inc share price performance charts on this page. Our technical summary section provides analysis on Kodiak Sciences share price buy/sell indicators using real-time data (or discuss the Kodiak Sciences (KOD) stock price today with other investors in the Kodiak Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ KOD share price (ISIN: US50015M1099) to enhance your trading decisions with our free investment tools and resources.
What Is the Kodiak Sciences Inc Share Price Today?
The Kodiak Sciences share price today is 25.420.
What Is the Stock Symbol for Kodiak Sciences Inc
The stock symbol (or 'ticker') for Kodiak Sciences Inc is "KOD."
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Kodiak Sciences Inc share price performance charts on this page. Our technical summary section provides analysis on Kodiak Sciences share price buy/sell indicators using real-time data (or discuss the Kodiak Sciences (KOD) stock price today with other investors in the Kodiak Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ KOD share price (ISIN: US50015M1099) to enhance your trading decisions with our free investment tools and resources.
What Is the Kodiak Sciences Inc Share Price Today?
The Kodiak Sciences share price today is 25.420.
What Is the Stock Symbol for Kodiak Sciences Inc
The stock symbol (or 'ticker') for Kodiak Sciences Inc is "KOD."
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.870
26.500
52 wk Range
1.920
31.180
KOD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.87026.500
52 wk Range
1.92031.180
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KOD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
30.714
Upside
+20.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
- Kodiak Sciences stock hits 52-week high at $29.52
- Investing.com
- Form 13D Kodiak Sciences Inc. For: 22 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Kodiak Sciences Company Profile
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company’s preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Kodiak Sciences Inc SWOT Analysis
Pipeline Promise | Explore Kodiaq Sciences' diverse eye disease treatment portfolio, including KSI-101, tarcocimab, and KSI-501, with key trial results expected in 2025-2026 |
Financial Hurdles | Delve into the company's financial challenges, with negative EPS forecasts and a declining stock price, balanced against its cash-rich balance sheet |
Market Positioning | Learn how Kodiaq Sciences aims to differentiate itself in the competitive biotech sector through innovative treatments and a new wearable OCT device |
Future Outlook | Analyst price targets range from $3 to $4, reflecting cautious optimism amid clinical trial uncertainties and potential market opportunities |
Compare KOD to Peers and Sector
Metrics to compare | KOD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKODPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.2x | −3.3x | −0.6x | |
PEG Ratio | 0.57 | 0.13 | 0.00 | |
Price/Book | 66.0x | 6.1x | 2.6x | |
Price / LTM Sales | - | 60.6x | 3.4x | |
Upside (Analyst Target) | 45.8% | 143.2% | 43.4% | |
Fair Value Upside | Unlock | 4.8% | 6.3% | Unlock |
Analyst Ratings
6 Buy
1 Hold
1 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 30.714
(+20.83% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-1.16 / -1.02
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Kodiak Sciences (KOD) Share Price Today?
The live Kodiak Sciences share price today is 25.420
What Stock Exchange Does Kodiak Sciences (KOD) Trade On?
Kodiak Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Kodiak Sciences?
The stock symbol (also called a 'ticker') for Kodiak Sciences is "KOD."
What Is the Current Kodiak Sciences Market Cap?
As of today, Kodiak Sciences market capitalisation is 1.57B.
What Is Kodiak Sciences's (KOD) Earnings Per Share (TTM)?
The Kodiak Sciences EPS is currently -4.12 (Trailing Twelve Months).
When Is the Next Kodiak Sciences Earnings Date?
Kodiak Sciences's next earnings report will be released on 26 Mar 2026.
Is KOD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Kodiak Sciences moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Kodiak Sciences Stock Split?
Kodiak Sciences has split 0 times. (See the KOD stock split history page for full effective split date and price information.)
How Many Employees Does Kodiak Sciences Have?
Kodiak Sciences has 123 employees.
What is the current trading status of Kodiak Sciences (KOD)?
As of 29 Jan 2026, Kodiak Sciences (KOD) is trading at a price of 25.420, with a previous close of 26.070. The stock has fluctuated within a day range of 24.870 to 26.500, while its 52-week range spans from 1.920 to 31.180.
What Is Kodiak Sciences (KOD) Price Target According to Analysts?
The average 12-month price target for Kodiak Sciences is USD30.714, with a high estimate of USD50 and a low estimate of USD2. 6 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +20.83% Upside potential.
What Is the KOD Premarket Price?
KOD's last pre-market stock price is 26.180. The pre-market share volume is 470.000, and the stock has decreased by 0.110, or 0.420%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.